1. ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment.
- Author
-
Au-Yeung CL, Yeung TL, Achreja A, Zhao H, Yip KP, Kwan SY, Onstad M, Sheng J, Zhu Y, Baluya DL, Co NN, Rynne-Vidal A, Schmandt R, Anderson ML, Lu KH, Wong STC, Nagrath D, and Mok SC
- Subjects
- Animals, Carcinoma, Ovarian Epithelial blood, Carcinoma, Ovarian Epithelial mortality, Carcinoma, Ovarian Epithelial therapy, Cell Line, Tumor transplantation, Cell Movement, Cell Proliferation, Cell Transformation, Neoplastic metabolism, Cytokines administration & dosage, Cytokines blood, Disease Models, Animal, Down-Regulation, Female, GPI-Linked Proteins administration & dosage, GPI-Linked Proteins blood, GPI-Linked Proteins metabolism, Gene Expression Regulation, Neoplastic, Humans, Lactoferrin metabolism, Lectins administration & dosage, Lectins blood, Matrix Metalloproteinase 1 metabolism, Mice, Neoplasm Invasiveness pathology, Ovarian Neoplasms blood, Ovarian Neoplasms mortality, Ovarian Neoplasms therapy, Ovary, Recombinant Proteins administration & dosage, Survival Rate, Tumor Microenvironment, Carcinoma, Ovarian Epithelial secondary, Cytokines metabolism, Lectins metabolism, Omentum pathology, Ovarian Neoplasms pathology, Peritoneal Neoplasms secondary
- Abstract
Advanced ovarian cancer usually spreads to the omentum. However, the omental cell-derived molecular determinants modulating its progression have not been thoroughly characterized. Here, we show that circulating ITLN1 has prognostic significance in patients with advanced ovarian cancer. Further studies demonstrate that ITLN1 suppresses lactotransferrin's effect on ovarian cancer cell invasion potential and proliferation by decreasing MMP1 expression and inducing a metabolic shift in metastatic ovarian cancer cells. Additionally, ovarian cancer-bearing mice treated with ITLN1 demonstrate marked decrease in tumor growth rates. These data suggest that downregulation of mesothelial cell-derived ITLN1 in the omental tumor microenvironment facilitates ovarian cancer progression.
- Published
- 2020
- Full Text
- View/download PDF